<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Recash test site | Tyler Kanstrup | Activity</title>
	<link>https://recash.wpsoul.net/members/sunopera36/activity/</link>
	<atom:link href="https://recash.wpsoul.net/members/sunopera36/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Tyler Kanstrup.</description>
	<lastBuildDate>Mon, 27 Jul 2026 22:58:01 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">5c92665996d694c6477d04c008b395af</guid>
				<title>Tyler Kanstrup posted an update: ease progression and evaluating the effectiveness of new [&#133;]</title>
				<link>https://recash.wpsoul.net/activity/p/136130/</link>
				<pubDate>Thu, 02 Jan 2025 08:14:55 +0000</pubDate>

									<content:encoded><![CDATA[<p>ease progression and evaluating the effectiveness of new therapies.Major advances in the study of inherited retinal diseases (IRDs) have placed efforts to develop treatments for these blinding conditions at the forefront of the emerging field of precision medicine. As a result, the growth of clinical trials for IRDs has increased rapidly over the&hellip;<span class="activity-read-more" id="activity-read-more-136130"><a href="https://recash.wpsoul.net/activity/p/136130/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">5ad2bd7d1516be8311df18a93f22f67b</guid>
				<title>Tyler Kanstrup became a registered member</title>
				<link>https://recash.wpsoul.net/activity/p/96827/</link>
				<pubDate>Fri, 20 Dec 2024 22:15:52 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>